FOUNTAIN VALLEY, CALIFORNIA -- (MARKET WIRE) -- February 12, 2007 -- Sutura, Inc. ("Sutura") (OTCBB: SUTU), an innovative developer of minimally invasive vascular suturing devices, announced today that it has successfully completed an advanced PFO Test of its HeartStitch™ suturing device. During the test, Sutura successfully demonstrated tactile capture of the septum secundum and septum primum in an in-vivo porcine subject, while using an ICE (Intra Cardiac Echocardiography) imaging catheter for guidance. The test was conducted by two of Sutura's senior clinical advisors Dr. Carlos Ruiz and Dr. John Crew. Dr. Ruiz successfully identified the defect edges and demonstrated the direct feedback required to capture the tissue and apply the suture with the new HeartStitch™ suturing device.
